Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 22, 2023

Direct Oral Anticoagulants vs Low–Molecular-Weight Heparin for Preventing Recurrent Venous Thromboembolism in Patients With Cancer

JAMA: The Journal of the American Medical Association


Additional Info

JAMA: The Journal of the American Medical Association
Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial
JAMA 2023 Jun 02;[EPub Ahead of Print], D Schrag, H Uno, R Rosovsky, C Rutherford, K Sanfilippo, JL Villano, M Drescher, N Jayaram, C Holmes, L Feldman, O Zattra, H Farrar-Muir, C Cronin, E Basch, A Weiss, JM Connors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading